Gyre Therapeutics, Inc. · NASDAQ:GYRE

Ye Weiguo sold 9,320 Gyre Therapeutics, Inc. shares (Form 4)

Traded May 18 to May 19, 2026 · Filed May 20, 2026

From May 18 to May 19, 2026, Ye Weiguo (Chief Operating Officer) sold 9,320 Gyre Therapeutics, Inc. shares at an average US$6.38 for US$59,418, leaving 700,000 shares. Filed May 20, 2026 (Form 4).

Sold: 9,320 shares
Price: US$6.38 average (US$6.37 to US$6.62)
Value: US$59,418
Holding after: 700,000 shares
Trading plan: No
Role: Chief Operating Officer

The filing in full

Date	Security	Transaction	Shares	Price	Holding after	Ownership
May 18, 2026	Common Stock	Option exercise	200	US$0.75	700,200	Direct
May 18, 2026	Common Stock	Sale	200	US$6.62	700,000	Direct
May 19, 2026	Common Stock	Option exercise	9,120	US$0.75	709,120	Direct
May 19, 2026	Common Stock	Sale	9,120	US$6.37	700,000	Direct

Source

View original at SEC

Related